# Elohim Partners

> Elohim Partners is a VC fund in Seoul backing Medical, Chemical and Database. See 6 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 6
- Last investment: Apr 2026
- Lead investor: 17%
- Last updated: Aug 2026

Elohim Partners is a private equity firm that mainly focuses on Asia middle-market buyouts and growth capital investments.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 17% |
| Chemical | 1 | 17% |
| Database | 1 | 17% |
| Recycling | 1 | 17% |
| Biotechnology | 1 | 17% |

13 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 33% |
| Series C | 2 | 33% |
| Seed | 1 | 17% |
| Series B | 1 | 17% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 3 | 50% |
| United States | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Dnotitia | Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large LanguageModels (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology. | $63.4M | Series A | Apr 21, 2026 |  |
| Dnotitia | Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large LanguageModels (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology. | $14.6M | Seed | Dec 10, 2024 |  |
| LDCarbon Co. | LD Carbon manufactures recycled resource materials designed to reduce carbon dioxide emissions. The company's eco-friendly material is manufactured by refining, processing, and commercializing combustion residues from combustion residues gas, oil, and steel that are generated through pyrolysis after crushing waste tires, enabling clients torecycle resource materials that reduce emissions, use crude oil resources, and solve environmental problems caused by waste tires for a sustainable future. | $29M | Series C | Jun 18, 2024 |  |
| EnergyX | EnergyX is a clean technology company that optimizes the lithium extraction process. The company was founded in 2018 and is headquartered in Fort Lauderdale, FL. | $50M | Series B | Oct 15, 2023 |  |
| LDCarbon Co. | LD Carbon manufactures recycled resource materials designed to reduce carbon dioxide emissions. The company's eco-friendly material is manufactured by refining, processing, and commercializing combustion residues from combustion residues gas, oil, and steel that are generated through pyrolysis after crushing waste tires, enabling clients torecycle resource materials that reduce emissions, use crude oil resources, and solve environmental problems caused by waste tires for a sustainable future. | $14.1M | Series A | Aug 16, 2022 |  |
| Wellmarker Bio | Their Company has developed a biomarker-based cancer drugs based on accumulated developmental experience and know-how. They have a new drug development institute including synthetic and bio-research and management support center.Utilizing R&D infrastructure from Asan Medical Center in Seoul Republic of Korea they are focusing on developingnew drugs that overcome resistance of existing therapeutic approaches.Additionally they are focusing on developing first-in-class biomarker-based drugs for medical unmet needs in various cancers such as colon cancer, lung cancer and liver cancer. | $11.8M | Series C | Oct 14, 2021 |  |

6 of 6 investments shown.

## Co-investors
- [HB Investment](https://shizune.co/investors/profile/hb-investment) — VC Fund, 2 deals together
- [Kolon Investment](https://shizune.co/investors/profile/kolon-investment) — VC Fund, 2 deals together
- [SJ Investment Partners](https://shizune.co/investors/profile/sj-investment-partners) — VC Fund, 2 deals together
- [TONY Investment](https://shizune.co/investors/profile/tony-investment) — VC Fund, 2 deals together
- [4 Pillars Investments](https://shizune.co/investors/profile/4-pillars-investments-llc) — VC Fund, 1 deal together
- [BonAngels Venture Partners](https://shizune.co/investors/profile/bon-angels) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Sustainability Investors in South Korea](https://shizune.co/investors/sustainability-investors-south-korea)
- [Sustainability VC Funds in South Korea](https://shizune.co/investors/sustainability-vc-funds-south-korea)
- [Impact Investors in South Korea](https://shizune.co/investors/impact-investors-south-korea)
- [Impact VC Funds in South Korea](https://shizune.co/investors/impact-vc-funds-south-korea)
- [Energy Investors in South Korea](https://shizune.co/investors/energy-investors-south-korea)

## FAQ

### What does Elohim Partners invest in?

Elohim Partners invests primarily in Medical, Chemical and Database startups, most often at Series A and Series C stage. Most of the 6 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Elohim Partners last invest?

The most recent investment recorded for Elohim Partners closed in Apr 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co